Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific: Alan Sachs and Karen Nelson

Thermo Fisher Scientific has appointed its current CSO Alan Sachs to the newly established role of chief medical officer. Sachs, who has served as CSO since 2016, will be succeeded by Karen Nelson, who previously served as president of the J. Craig Venter Institute. Both will join the company leadership team in August 2021.

In his new role, Sachs will help identify and promote the adoption of new technologies that benefit customers in the clinical space, and he will lead the company's medical affairs program, Thermo Fisher said. Nelson, who joined Thermo Fisher on July 6, currently serves as editor-in-chief of the journals Microbial Ecology and the newly formed PNAS Nexus. She is also an elected member of the National Academy of Sciences and a Fellow of the American Academy of Microbiology.

The Scan

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.

Australian Survey Points to Public Support for Genetic Risk Disclosure in Relatives of At-Risk Individuals

A survey in the European Journal of Human Genetics suggests most adult Australians are in favor of finding out if a relative tests positive for a medically actionable genetic variant.

Study Links Evolution of Stony Coral Skeleton to Bicarbonate Transporter Gene

A PNAS paper focuses on a skeleton-related bicarbonate transporter gene introduced to stony coral ancestors by tandem duplication.

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.